Gene: OGFOD2
Official Full Name: 2-oxoglutarate and iron dependent oxygenase domain containing 2provided by HGNC
Gene Summary: Predicted to enable several functions, including L-ascorbic acid binding activity; dioxygenase activity; and iron ion binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15506 | OGFOD2 Knockout cell line (HeLa) | Human | OGFOD2 | 1:3~1:6 | Negative | Online Inquiry |
KO15507 | OGFOD2 Knockout cell line (HCT 116) | Human | OGFOD2 | 1:2~1:4 | Negative | Online Inquiry |
KO15508 | OGFOD2 Knockout cell line (HEK293) | Human | OGFOD2 | 1:3~1:6 | Negative | Online Inquiry |
KO15509 | OGFOD2 Knockout cell line (A549) | Human | OGFOD2 | 1:3~1:4 | Negative | Online Inquiry |
OGFOD2 Gene Knockout Cell Lines are genetically engineered cells that have been modified to remove the OGFOD2 gene, which encodes an enzyme involved in the regulation of protein synthesis and ribosome biogenesis. This knockout model serves as a powerful tool to investigate the multifaceted roles of OGFOD2 in cellular processes, such as stress response, cell cycle regulation, and gene expression control. By eliminating this gene, researchers can gain insights into the pathways influenced by OGFOD2, thereby enhancing our understanding of dysregulated cellular mechanisms that could lead to various diseases.
The primary function of OGFOD2 involves the post-translational modification of certain proteins, which can influence their stability and activity within the cell. By utilizing the OGFOD2 Gene Knockout Cell Lines, scientists can explore aberrations in protein homeostasis and the resulting cellular implications, thus driving research into therapeutic strategies targeting related dysregulations. This cell line is especially pertinent in cancer research, where OGFOD2 may affect tumor growth and response to treatment.
What sets OGFOD2 Gene Knockout Cell Lines apart from other knockout models is their specificity and reliability for studying the direct effects of OGFOD2 deletion in a controlled environment. These cell lines are also validated for consistent performance in various assays, including proliferation, apoptosis, and migration studies, establishing them as a robust platform for experimental research.
For researchers and clinicians, employing OGFOD2 Knockout Cell Lines can significantly accelerate the advancement of biological knowledge and therapeutic development. Their potential applications extend into drug discovery, biomarker identification, and therapeutic targeting, making them an invaluable resource in both academic and clinical laboratories.
Our company prides itself on expertise in producing high-quality biological reagents. With a focus on precision and reliability, we are committed to supporting the scientific community with innovative solutions, including the OGFOD2 Gene Knockout Cell Lines, which are designed to facilitate cutting-edge research and foster the discovery of novel therapeutic approaches.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.